Investors
AI DRUG DISCOVERY
PRIMED FOR REAL-WORLD
DEVELOPMENT
Who we are
RELENTLESS MEDICINE DISCOVERY
We unite computation and RNAi to discover and develop life-transforming medicines. Our proprietary GalOmic™ RNAi platform and LLibra™ computational engine work together to accelerate discovery, reduce risk, and advance a pipeline of novel RNAi medicines toward patients.
[Testimonial]
The potential of Tangram as a biotech that fully integrates the latest advances in computation and artificial intelligence is clear. Ultimately, this leads to the development of life-transforming RNAi medicines for patients.
Ali Mortazavi, Chief Executive Officer
About our business
Company Overview
Find out more about Tangram Therapeutics. See the latest updates and developments in our business.
BUSINESS DETAILS
-
Registered office:
Unit 4B, Level 4, 4 Kingdom Street, London W2 6PY
For all investor enquiries, please contact:Email: ir@tangramtx.com
